AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 196 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 4.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,000 | – | 100 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 100 | -97.4% | 0.00% | -100.0% |
| Q2 2018 | $75,000 | +212.5% | 3,887 | +110.8% | 0.01% | +150.0% |
| Q4 2017 | $24,000 | -50.0% | 1,844 | -29.7% | 0.00% | -60.0% |
| Q3 2017 | $48,000 | +500.0% | 2,623 | +634.7% | 0.01% | +400.0% |
| Q3 2016 | $8,000 | -72.4% | 357 | -70.6% | 0.00% | -66.7% |
| Q2 2016 | $29,000 | -39.6% | 1,214 | -24.5% | 0.00% | -62.5% |
| Q4 2015 | $48,000 | -50.0% | 1,608 | -33.7% | 0.01% | -52.9% |
| Q3 2015 | $96,000 | +700.0% | 2,424 | +1217.4% | 0.02% | +750.0% |
| Q2 2015 | $12,000 | -7.7% | 184 | -24.9% | 0.00% | -33.3% |
| Q1 2015 | $13,000 | -90.4% | 245 | -92.4% | 0.00% | -93.2% |
| Q4 2014 | $136,000 | +1411.1% | 3,206 | +986.8% | 0.04% | +4300.0% |
| Q3 2014 | $9,000 | -83.0% | 295 | -88.7% | 0.00% | -87.5% |
| Q2 2014 | $53,000 | – | 2,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bleichroeder LP | 1,299,994 | $12,220,000 | 2.19% |
| Camber Capital Management LP | 8,780,000 | $82,532,000 | 2.18% |
| Palo Alto Investors LP | 3,003,875 | $28,236,000 | 1.55% |
| ARMISTICE CAPITAL, LLC | 4,120,000 | $38,728,000 | 1.40% |
| Permanens Capital L.P. | 359,311 | $3,378,000 | 1.17% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 31,582 | $297,000 | 0.21% |
| BOOTHBAY FUND MANAGEMENT, LLC | 348,000 | $3,271,000 | 0.20% |
| Teza Capital Management LLC | 20,300 | $191,000 | 0.11% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 767,135 | $7,211,000 | 0.08% |
| Livforsakringsbolaget Skandia, Omsesidigt | 38,800 | $365,000 | 0.04% |